Skip to content

Neurobiological mechanisms of depression in Parkinson's disease

Neurobiological mechanisms of depression in Parkinson's disease - Depression in Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37738
Enrollment
75
Registered
2012-04-19
Start date
2012-11-05
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

None listed

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Idiopatic Parkinson's disease Age between 30 and 70 Hoehn & Yahr stage 1 - 2.5 (mild to moderate disease) ADL independent

Exclusion criteria

Exclusion criteria: Severe depression according to the DSM IV Dementia Use of antidepressants or other psycho-active drugs Severe comorbidity (including neurologic and psychiatric comorbidity) Contra-indications for MRI

Design outcomes

Primary

MeasureTime frame
We will measure error rates and brain activity using fMRI while participants perform a feedback-based learning task on a computer. Sensitivity to reward and punishment will be also tested outside the context of learning (after scanning) using two additional behavioral tasks. Furthermore, we will investigate the association between depressive symptoms, sensitivity to reward and genetic polymorphisms in dopaminergic genes, for instance DAT1.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)